Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
423.09
-4.11 (-0.96%)
At close: Aug 1, 2025, 4:00 PM
423.29
+0.20 (0.05%)
After-hours: Aug 1, 2025, 7:32 PM EDT
Medpace Holdings Revenue
Medpace Holdings had revenue of $603.31M in the quarter ending June 30, 2025, with 14.24% growth. This brings the company's revenue in the last twelve months to $2.23B, up 9.94% year-over-year. In the year 2024, Medpace Holdings had annual revenue of $2.11B with 11.84% growth.
Revenue (ttm)
$2.23B
Revenue Growth
+9.94%
P/S Ratio
5.73
Revenue / Employee
$378,269
Employees
5,900
Market Cap
11.89B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.11B | 223.21M | 11.84% |
Dec 31, 2023 | 1.89B | 425.85M | 29.17% |
Dec 31, 2022 | 1.46B | 317.62M | 27.80% |
Dec 31, 2021 | 1.14B | 216.45M | 23.38% |
Dec 31, 2020 | 925.93M | 64.96M | 7.54% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
MEDP News
- 10 days ago - Medpace Holdings, Inc. (MEDP) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase - Seeking Alpha
- 11 days ago - This Clinical Trials Stock Just Soared 40%. What Caused It to Pop. - Barrons
- 11 days ago - Top 2 Health Care Stocks You May Want To Dump This Quarter - Benzinga
- 11 days ago - Medpace Holdings, Inc. Reports Second Quarter 2025 Results - Business Wire
- 5 weeks ago - Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025 - Business Wire
- 3 months ago - Medpace Holdings, Inc. (MEDP) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Medpace Holdings, Inc. Reports First Quarter 2025 Results - Business Wire